Keeping an eye on $NOVT after a roughly 12% two-session drop despite strong organic growth, improving profitability and cash flow, and raised 2026 guidance. The main risk is the Riverpoint acquisition; leverage increased materially, so integration and execution matter more now. There may still be details the market is pricing in that I haven’t caught yet;this is a watch, not a verdict.
476 views
0 Comments
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
